University of Alabama at Birmingham | GenomeWeb

University of Alabama at Birmingham

The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.

The agency has awarded five-year grants to three research institutions to promote education in genomic medicine among physicians and biomedical scientists.

Genome-wide association and other genetic studies hint at variants increasing subsequent neoplasm risk in individuals treated for cancer during childhood.

Their clinical trial will compare the effectiveness of tissue biopsies and liquid biopsies for tumor detection and monitoring.

A partnership with the Foundation for Mitochondrial Medicine and Seahorse Bioscience, the clinical program will evaluate Seahorse's XF Technology.

A University of Alabama, Birmingham team used the Illumina MiSeq platform to perform next-generation sequencing on 15 strains of M. pneumoniae

Infection with Fusobacterium necrophorum resembles strep throat, and may be as prevalent in young adult populations.

Work at the institute will focus on new discoveries in fields including cancer, cardiovascular disease, infectious disease, immunology, and others. 

A genome-wide association study by researchers at several US and international institutions has found a novel variant — rs12777823 — that explains some of the variability in warfarin metabolism in African-American individuals and could potentially improve the effectiveness of pha

Researchers from the University of Alabama at Birmingham and the University of Washington have shown that they can tweak the way the Mycobacterium smegmatis porin A, or MspA, protein is produced — a step that is expected to lead to more refined methods for tailoring the

Pages

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.